Skip to content
TrustList
BioNet Holding logo
Venture capital firm

BioNet Holding

Munich biopharma company developing drug programmes and licensing them to pharmaceutical partners

BioNet Holding cover

About BioNet Holding

BioNet Holding is linked to BioNet Pharma GmbH, a drug development company in Munich. The company grew out of Scil Technology, which itself came from the Scil Group that was set up in 1999. It works on medicines, taking programmes through early research and clinical testing.

What BioNet Holding offers

  • Drug development programmes — several projects have passed preclinical proof of concept.
  • Clinical development — two programmes completed clinical phase II while the business was still Scil Technology.
  • Licensing — deals with established pharmaceutical companies for development programmes across different indications.

Key facts

  • Based in: Munich
  • Origins: Scil Group, founded in 1999
  • Former name: Scil Technology GmbH
  • Current entity: BioNet Pharma GmbH

Profile written by TrustList from the business's own published information, Oct 2026.

Ask TrustList to introduce you to BioNet Holding

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of BioNet Holding

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about BioNet Holding.

BioNet Holding alternatives

Similar listings buyers compare against this one.

Product discovery software for B2B and B2C sellers, covering search, guided selling and product content

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

Decentralised bandwidth network on which developers build and users run censorship-resistant VPN applications